Share this article
Share this article
MINNEAPOLIS, March 5, 2021 /PRNewswire/ Children born to women taking certain medications for epilepsy during pregnancy have no developmental delays at age three when compared to children of healthy women without epilepsy, according to a preliminary study released March 4, 2021, that will be presented at the American Academy of Neurology s 73
rd Annual Meeting being held virtually April 17 to 22, 2021. Most of the women with epilepsy in the study took either lamotrigine or levetiracetam during their pregnancy, or a combination of the two. Having a seizure during pregnancy may not only harm the mother but possibly the baby as well, so seizure control is an important part of prenatal care, said study author Kimford J. Meador, M.D., of Stanford University in Stanford, Calif., and a Fellow of the American Academy of Neurology. Yet, antiseizure drugs are known to cause birth defects or neurobehavioral problems, but these effects vary widely
TG Therapeutics to Present Results from the ULTIMATE I & II Phase 3 Trials Evaluating Ublituximab in Multiple Sclerosis at the Upcoming American Academy of Neurology 73rd Annual Meeting
gurufocus.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from gurufocus.com Daily Mail and Mail on Sunday newspapers.
Anti-CD20s Linked to Higher COVID-19 Severity in MS
medscape.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medscape.com Daily Mail and Mail on Sunday newspapers.